The current status of multivisceral transplantation

BACKGROUND:Multivisceral transplantation (MVTx) is concurrent transplantation of the stomach, spleen pancreaticoduodenal complex, and intestine, with (MVTx) or without (modified MVTx) the liver. MVTx has been performed more frequently worldwide, and the survival of patients approximates that of pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatobiliary & pancreatic diseases international 2009-08, Vol.8 (4), p.345-350
Hauptverfasser: Mao, Qi, Li, You-Sheng, Li, Jie-Shou
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 350
container_issue 4
container_start_page 345
container_title Hepatobiliary & pancreatic diseases international
container_volume 8
creator Mao, Qi
Li, You-Sheng
Li, Jie-Shou
description BACKGROUND:Multivisceral transplantation (MVTx) is concurrent transplantation of the stomach, spleen pancreaticoduodenal complex, and intestine, with (MVTx) or without (modified MVTx) the liver. MVTx has been performed more frequently worldwide, and the survival of patients approximates that of patients who have undergone transplantation of other solid organs. This review introduces the recent development in MVTx. DATA SOURCES:Two English-language medical databases MEDLINE and SPRINGERLINK, were searched for articles on "multivisceral transplantation", "graft procurement", "immunosuppression,"and related topics. RESULT:MVTx has been the optimal therapy for the intestine with liver failure and/or failure of several other organs, despite many difficulties in preventing rejection and infection. CONCLUSION:Further study is needed to improve the long-term survival of recipients and reduce the complications.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_733967210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>1003033238</cqvip_id><sourcerecordid>733967210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c238t-4eec481565f4034c217cb8d43c522617aaf2f0c2f7b9e65f1ddeb93c29822f923</originalsourceid><addsrcrecordid>eNpFz0tLAzEQwPEcFFurX0EWPHhaSGayeRyl-IKCl3pestmkXdlHm2QFv72RVjzNYX4M_7kgS8a1LlFJWJDrGD8pBaUqcUUWTAshOGVLgtu9K-wcghtTEZNJcywmXwxzn7qvLloXTF-kYMZ46M2Y99003pBLb_robs9zRT6en7br13Lz_vK2ftyUFlClkjtnuWKVqDynyC0waRvVcrQVgGDSGA-eWvCy0S4j1rau0WhBKwCvAVfk4XT3EKbj7GKqh9-iPoe4aY61RNRCAqNZ3p3l3AyurQ-hG0z4rv_-zOD-BOx-GnfHbtz9G0qRIuZk_AEv71lB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733967210</pqid></control><display><type>article</type><title>The current status of multivisceral transplantation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Mao, Qi ; Li, You-Sheng ; Li, Jie-Shou</creator><creatorcontrib>Mao, Qi ; Li, You-Sheng ; Li, Jie-Shou</creatorcontrib><description><![CDATA[BACKGROUND:Multivisceral transplantation (MVTx) is concurrent transplantation of the stomach, spleen pancreaticoduodenal complex, and intestine, with (MVTx) or without (modified MVTx) the liver. MVTx has been performed more frequently worldwide, and the survival of patients approximates that of patients who have undergone transplantation of other solid organs. This review introduces the recent development in MVTx. DATA SOURCES:Two English-language medical databases MEDLINE and SPRINGERLINK, were searched for articles on &quot;multivisceral transplantation&quot;, &quot;graft procurement&quot;, &quot;immunosuppression,&quot;and related topics. RESULT:MVTx has been the optimal therapy for the intestine with liver failure and/or failure of several other organs, despite many difficulties in preventing rejection and infection. CONCLUSION:Further study is needed to improve the long-term survival of recipients and reduce the complications.]]></description><identifier>ISSN: 1499-3872</identifier><identifier>PMID: 19666401</identifier><language>eng</language><publisher>Singapore</publisher><subject>abdominal ; Duodenum - transplantation ; graft ; Graft Rejection - immunology ; Graft Rejection - prevention &amp; control ; Graft Survival ; Humans ; Immunosuppression ; Liver Transplantation - trends ; Multiple Organ Failure - mortality ; Multiple Organ Failure - surgery ; multivisceral ; Organ Transplantation - adverse effects ; Organ Transplantation - mortality ; Organ Transplantation - trends ; Pancreas Transplantation - trends ; Parenteral Nutrition ; procurement ; Spleen - transplantation ; Stomach - transplantation ; Time Factors ; transplantation ; Transplantation Tolerance ; Treatment Outcome ; wall</subject><ispartof>Hepatobiliary &amp; pancreatic diseases international, 2009-08, Vol.8 (4), p.345-350</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/89801X/89801X.jpg</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19666401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mao, Qi</creatorcontrib><creatorcontrib>Li, You-Sheng</creatorcontrib><creatorcontrib>Li, Jie-Shou</creatorcontrib><title>The current status of multivisceral transplantation</title><title>Hepatobiliary &amp; pancreatic diseases international</title><addtitle>Hepatobiliary &amp; Pancreatic Diseases International</addtitle><description><![CDATA[BACKGROUND:Multivisceral transplantation (MVTx) is concurrent transplantation of the stomach, spleen pancreaticoduodenal complex, and intestine, with (MVTx) or without (modified MVTx) the liver. MVTx has been performed more frequently worldwide, and the survival of patients approximates that of patients who have undergone transplantation of other solid organs. This review introduces the recent development in MVTx. DATA SOURCES:Two English-language medical databases MEDLINE and SPRINGERLINK, were searched for articles on &quot;multivisceral transplantation&quot;, &quot;graft procurement&quot;, &quot;immunosuppression,&quot;and related topics. RESULT:MVTx has been the optimal therapy for the intestine with liver failure and/or failure of several other organs, despite many difficulties in preventing rejection and infection. CONCLUSION:Further study is needed to improve the long-term survival of recipients and reduce the complications.]]></description><subject>abdominal</subject><subject>Duodenum - transplantation</subject><subject>graft</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - prevention &amp; control</subject><subject>Graft Survival</subject><subject>Humans</subject><subject>Immunosuppression</subject><subject>Liver Transplantation - trends</subject><subject>Multiple Organ Failure - mortality</subject><subject>Multiple Organ Failure - surgery</subject><subject>multivisceral</subject><subject>Organ Transplantation - adverse effects</subject><subject>Organ Transplantation - mortality</subject><subject>Organ Transplantation - trends</subject><subject>Pancreas Transplantation - trends</subject><subject>Parenteral Nutrition</subject><subject>procurement</subject><subject>Spleen - transplantation</subject><subject>Stomach - transplantation</subject><subject>Time Factors</subject><subject>transplantation</subject><subject>Transplantation Tolerance</subject><subject>Treatment Outcome</subject><subject>wall</subject><issn>1499-3872</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFz0tLAzEQwPEcFFurX0EWPHhaSGayeRyl-IKCl3pestmkXdlHm2QFv72RVjzNYX4M_7kgS8a1LlFJWJDrGD8pBaUqcUUWTAshOGVLgtu9K-wcghtTEZNJcywmXwxzn7qvLloXTF-kYMZ46M2Y99003pBLb_robs9zRT6en7br13Lz_vK2ftyUFlClkjtnuWKVqDynyC0waRvVcrQVgGDSGA-eWvCy0S4j1rau0WhBKwCvAVfk4XT3EKbj7GKqh9-iPoe4aY61RNRCAqNZ3p3l3AyurQ-hG0z4rv_-zOD-BOx-GnfHbtz9G0qRIuZk_AEv71lB</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Mao, Qi</creator><creator>Li, You-Sheng</creator><creator>Li, Jie-Shou</creator><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20090801</creationdate><title>The current status of multivisceral transplantation</title><author>Mao, Qi ; Li, You-Sheng ; Li, Jie-Shou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c238t-4eec481565f4034c217cb8d43c522617aaf2f0c2f7b9e65f1ddeb93c29822f923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>abdominal</topic><topic>Duodenum - transplantation</topic><topic>graft</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - prevention &amp; control</topic><topic>Graft Survival</topic><topic>Humans</topic><topic>Immunosuppression</topic><topic>Liver Transplantation - trends</topic><topic>Multiple Organ Failure - mortality</topic><topic>Multiple Organ Failure - surgery</topic><topic>multivisceral</topic><topic>Organ Transplantation - adverse effects</topic><topic>Organ Transplantation - mortality</topic><topic>Organ Transplantation - trends</topic><topic>Pancreas Transplantation - trends</topic><topic>Parenteral Nutrition</topic><topic>procurement</topic><topic>Spleen - transplantation</topic><topic>Stomach - transplantation</topic><topic>Time Factors</topic><topic>transplantation</topic><topic>Transplantation Tolerance</topic><topic>Treatment Outcome</topic><topic>wall</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mao, Qi</creatorcontrib><creatorcontrib>Li, You-Sheng</creatorcontrib><creatorcontrib>Li, Jie-Shou</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatobiliary &amp; pancreatic diseases international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mao, Qi</au><au>Li, You-Sheng</au><au>Li, Jie-Shou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The current status of multivisceral transplantation</atitle><jtitle>Hepatobiliary &amp; pancreatic diseases international</jtitle><addtitle>Hepatobiliary &amp; Pancreatic Diseases International</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>8</volume><issue>4</issue><spage>345</spage><epage>350</epage><pages>345-350</pages><issn>1499-3872</issn><abstract><![CDATA[BACKGROUND:Multivisceral transplantation (MVTx) is concurrent transplantation of the stomach, spleen pancreaticoduodenal complex, and intestine, with (MVTx) or without (modified MVTx) the liver. MVTx has been performed more frequently worldwide, and the survival of patients approximates that of patients who have undergone transplantation of other solid organs. This review introduces the recent development in MVTx. DATA SOURCES:Two English-language medical databases MEDLINE and SPRINGERLINK, were searched for articles on &quot;multivisceral transplantation&quot;, &quot;graft procurement&quot;, &quot;immunosuppression,&quot;and related topics. RESULT:MVTx has been the optimal therapy for the intestine with liver failure and/or failure of several other organs, despite many difficulties in preventing rejection and infection. CONCLUSION:Further study is needed to improve the long-term survival of recipients and reduce the complications.]]></abstract><cop>Singapore</cop><pmid>19666401</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1499-3872
ispartof Hepatobiliary & pancreatic diseases international, 2009-08, Vol.8 (4), p.345-350
issn 1499-3872
language eng
recordid cdi_proquest_miscellaneous_733967210
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects abdominal
Duodenum - transplantation
graft
Graft Rejection - immunology
Graft Rejection - prevention & control
Graft Survival
Humans
Immunosuppression
Liver Transplantation - trends
Multiple Organ Failure - mortality
Multiple Organ Failure - surgery
multivisceral
Organ Transplantation - adverse effects
Organ Transplantation - mortality
Organ Transplantation - trends
Pancreas Transplantation - trends
Parenteral Nutrition
procurement
Spleen - transplantation
Stomach - transplantation
Time Factors
transplantation
Transplantation Tolerance
Treatment Outcome
wall
title The current status of multivisceral transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T15%3A35%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20current%20status%20of%20multivisceral%20transplantation&rft.jtitle=Hepatobiliary%20&%20pancreatic%20diseases%20international&rft.au=Mao,%20Qi&rft.date=2009-08-01&rft.volume=8&rft.issue=4&rft.spage=345&rft.epage=350&rft.pages=345-350&rft.issn=1499-3872&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E733967210%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733967210&rft_id=info:pmid/19666401&rft_cqvip_id=1003033238&rfr_iscdi=true